Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying stakeholder behaviors for competency-based pharmacy education: A stage 1 behavior change wheel analysis.

Research in social & administrative pharmacy : RSAP·2026
Same author

A bibliometric analysis describing the global scope of pharmacist roles (2000-2024).

Journal of the American Pharmacists Association : JAPhA·2026
Same author

A Bibliometric Analysis of Pharmacist-Delivered Care: Global Trends, Outcomes, and Practice Settings (2000-2024).

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Future-Proofing Pharmacy: A Stakeholder-Informed Forecast of Workforce and Education Needs.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

A unifying vision for pharmacy: Defining professional identity through stakeholder perspectives.

Journal of the American Pharmacists Association : JAPhA·2025
Same author

Best Practices for Interprofessional Education to Meet the Curriculum Outcomes and Entrustable Professional Activities.

American journal of pharmaceutical education·2024

Related Experiment Video

Updated: Jul 18, 2026

Project-Based Learning Guidelines for Health Sciences Students: An Analysis with Data Mining and Qualitative Techniques
13:44

Project-Based Learning Guidelines for Health Sciences Students: An Analysis with Data Mining and Qualitative Techniques

Published on: December 9, 2022

Student satisfaction and academic performance in a dual PharmD/MBA degree program.

Elinor C G Chumney1, Kelly R Ragucci

  • 1South Carolina College of Pharmacy, USA.

American Journal of Pharmaceutical Education
|December 7, 2006
PubMed
Summary

Students in the dual Doctor of Pharmacy/Master of Business Administration (PharmD/MBA) program reported high satisfaction and achieved higher GPAs than peers. This academic experience highlights program success.

Related Experiment Videos

Last Updated: Jul 18, 2026

Project-Based Learning Guidelines for Health Sciences Students: An Analysis with Data Mining and Qualitative Techniques
13:44

Project-Based Learning Guidelines for Health Sciences Students: An Analysis with Data Mining and Qualitative Techniques

Published on: December 9, 2022

Area of Science:

  • Pharmacy Education
  • Business Administration
  • Higher Education

Background:

  • The dual Doctor of Pharmacy/Master of Business Administration (PharmD/MBA) program integrates pharmaceutical sciences with business acumen.
  • Evaluating student academic experience and satisfaction is crucial for program development.

Purpose of the Study:

  • To assess the academic experience and satisfaction of students in the dual PharmD/MBA program.
  • To compare the academic performance (GPA) of dual-degree students with traditional pharmacy and business students.

Main Methods:

  • A satisfaction survey was distributed to 32 active students in the PharmD/MBA program.
  • Grade point averages (GPAs) from both pharmacy and business coursework were collected for comparative analysis.

Main Results:

  • The dual PharmD/MBA program exhibited a higher percentage of female and minority students compared to the general pharmacy cohort.
  • Survey responses from 18 (56%) students were predominantly positive.
  • Dual-degree students achieved a higher mean GPA in pharmacy coursework (3.37 vs. 3.08, p < 0.001) and a comparable GPA in business coursework (3.72 vs. 3.64) versus non-dual-degree students.

Conclusions:

  • Students in the dual PharmD/MBA program demonstrated superior academic performance.
  • The program fosters a high level of student satisfaction, indicating a successful educational model.